report
What lies ahead APAC’s medical speech recognition software market?
What lies ahead APAC’s medical speech recognition software market?
There is a growing emphasis on improved clinical efficiency in countries like India and China.
Alzheimer’s disease market across 8MM to hit 19.3b by 2033
DMTs are expected to account for 73.5% of the global market.
Global chronic disease management market to reach $1.1t by 2029
The economic burden of the condition is projected to cost the global economy $47t by 2030.
Qatar’s health expenditure to be valued at $12.8b by 2029
It is projected to grow at 13.6% CAGR.
APAC healthcare investments diversify as China dealmaking slows
India emerges as a prominent alternative amidst its growing middle class.
HIV-diagnosed cases in major markets projected to hit 2.2 million by 2033
Japan will have the fewest cases at around 34,400.
Implantable neurostimulation devices market to reach $13.13b by 2028
Its growth is attributed to the rising incidence of neurological disorders.
Glaucoma market to hit $2.5b in seven major markets by 2033
A report predicts the launch of six late-stage pipeline drugs during this period.
Global testosterone replacement therapy market to rise by $461m by 2029
Its growth is driven by a rising awareness of hypogonadism.
Heart failure market across 7MM to grow at 9.6% CAGR until 2032
One driver is the introduction of drugs targeting unmet needs.
Patient monitoring accessories market to reach $16.87b by 2032
Enhanced ECG electrodes and blood pressure cuffs have improved sensitivity and durability.
What factors drive the global cell and gene therapy tools market?
One drive is the rising prevalence of chronic diseases like cancer and diabetes.
Global medical affairs outsourcing market to hit $2.83b by 2028
AI-driven platforms are being adopted for more efficient data management and analysis.
AI-driven adaptive cardiac devices to improve heart disease treatment
These solutions highlight the industry’s shift to precision medicine.
Global endoscopic closure devices market to grow by $825.7m by 2029
Its expansion is attributed to the rising prevalence of gastrointestinal conditions.
Near-infrared imaging market set for 4% CAGR growth through 2032
It is primarily driven by the medical sector.
Point-of-care diagnostics market to reach $65.9b by 2029
It is expected to grow at a CAGR of 10.2% during the forecast period.
Most Read
1. Singapore launches online tool for health insurance planning 2. Asian Hospital’s CyberKnife tracks tumours in real time 3. Prudential Hong Kong introduces ophthalmology direct billing at EKMC 4. NUH, Jaga-Me ink MoU for supportive and palliative care 5. Japan’s medical device market to be valued at $42.9b by 2029Resource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
PicoSure® Pro takes picosecond laser technology to unprecedented levels of performance.
Commentary
Why preventing diseases through adult immunisation is essential to keeping Singaporeans healthy